USCareCheck

CMS certification 070022

Yale-New Haven Hospital

20 York St, New Haven, CT 06504

Acute Care Hospitals Emergency services Birthing-friendly

Yale-New Haven Hospital has a CMS overall rating of 5 out of 5 stars. 69% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. Of the 27 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 11 and worse on 3. Emergency patients spend a median of 3 h 18 min in its emergency department before leaving (US median 2 h 42 min).

Every figure on this page is published by CMS; we arrange and explain it, and score nothing ourselves.

CMS overall rating 5/5 CMS summary of quality measures
Would definitely recommend 69% US average 71%
Patient survey rating 3/5 863 completed surveys
Compared with the nation 3 worse 11 better of 27 measures CMS could compare

What patients said

Answers from patients who stayed here, collected by CMS in the national HCAHPS survey: 863 completed surveys, 23% response rate, Oct 2024 – Sep 2025.

Would definitely recommend the hospital
69%
CT 68% · US 71% · 3 of 5 stars
Rated the hospital 9 or 10 out of 10
64%
CT 66% · US 72% · 2 of 5 stars
Nurses always communicated well
76%
CT 78% · US 80% · 3 of 5 stars
Doctors always communicated well
76%
CT 77% · US 80% · 3 of 5 stars
Staff always explained new medicines
58%
CT 59% · US 62% · 2 of 5 stars
Given information about recovering at home
87%
CT 87% · US 86% · 4 of 5 stars
Room was always clean
67%
CT 71% · US 74% · 3 of 5 stars
Always quiet at night
45%
CT 48% · US 60% · 2 of 5 stars

This hospital Connecticut average US average

Emergency department

How long emergency patients spent here and how some time-critical care went, from CMS's timely and effective care measures, Oct 2024 – Sep 2025. CMS classes this emergency department's patient volume as very high; busier departments tend to have longer times, so the national median for departments of the same volume is shown too. These are medians over a year of visits, not a live wait time.

Measure This hospital CT US
Median time in the emergency department before leaving Lower is better · 347 visits sampled · US median for EDs of the same volume: 3 h 21 min 3 h 18 min 3 h 12 min 2 h 42 min
Median time for psychiatric and mental health patients Lower is better · 29 visits sampled 2 h 41 min 4 h 7 min 4 h 17 min
Left before being seen Lower is better · 227,953 patients 2% 2% 2%
Stroke symptoms: brain scan read within 45 minutes Higher is better · 11 patients 91% 77% 69%
Severe sepsis and septic shock: all recommended care given Higher is better · 155 patients 37% 57% 65%

How Yale-New Haven Hospital compares with nearby hospitals

The closest hospitals of the same kind that CMS rates or surveys - the same city first, then the same county and ZIP area. Every figure is CMS's: the overall star rating, the share of patients who would definitely recommend the hospital, the median time emergency patients spent before leaving, and how many death, complication, infection and readmission measures CMS found better or worse than the national rate.

Hospital CMS stars Would recommend ER median time Vs the nation
Yale-New Haven HospitalThis hospital5/569%3 h 18 min11 better 3 worse
West Haven VA Medical CenterSame county · West Haven3/576%—2 better 2 worse
Midstate Medical CenterSame county · Meriden4/576%3 h 40 min4 better
Griffin HospitalSame county · Derby4/576%2 h 45 min1 better 3 worse
Saint Mary's HospitalSame county · Waterbury3/560%4 h 9 min2 better
Waterbury HospitalSame county · Waterbury2/555%3 h 47 min4 better

Hospitals differ in size and in how sick their patients are. CMS adjusts its outcome measures for that, but a star or a percentage is a starting point for questions, not a verdict. All hospitals in New Haven.

Deaths

How many patients died within 30 days of admission, adjusted by CMS for how sick they were. Lower is better. Data from Jul 2022 – Jun 2025.

Measure CMS comparison This hospital National
All patients, hospital-wide 11,810 cases Too few cases 2.2% 3.9%
Heart attack 352 cases Too few cases 9.4% 11.9%
Heart failure 1,097 cases Too few cases 7.1% 11.1%
Pneumonia 1,527 cases Too few cases 10.4% 15.2%
Stroke 985 cases Too few cases 11.6% 11.9%
COPD 221 cases Too few cases 7.5% 8.6%
Heart bypass surgery (CABG) 133 cases Too few cases 1.6% 2.4%

Complications

How often patients had serious complications, most of them after surgery, adjusted for how sick they were. Lower is better. Data from Jul 2022 – Jun 2024.

5 better than the nation 7 no different
Measure CMS comparison This hospital National
Serious complications, combined measure Better 0.7 likely 0.53 – 0.87 1
After hip or knee replacement 261 cases Too few cases 3.6% 4.1%
Deaths after a serious but treatable surgical complication 374 cases Better 137.48 per 1,000 likely 105.24 per 1,000 – 169.71 per 1,000 173.3 per 1,000
Pressure ulcers (bed sores) 19,374 cases No different 0.65 per 1,000 likely 0.31 per 1,000 – 0.98 per 1,000 0.63 per 1,000
Collapsed lung caused by a procedure 20,172 cases No different 0.12 per 1,000 likely 0 per 1,000 – 0.28 per 1,000 0.21 per 1,000
Broken bones from falls in the hospital 21,425 cases No different 0.28 per 1,000 likely 0.13 per 1,000 – 0.43 per 1,000 0.27 per 1,000
Bleeding or hematoma after surgery 4,745 cases Better 1.18 per 1,000 likely 0.15 per 1,000 – 2.22 per 1,000 2.34 per 1,000
Kidney injury needing dialysis after surgery 2,232 cases No different 1.38 per 1,000 likely 0.31 per 1,000 – 2.45 per 1,000 1.67 per 1,000
Breathing failure after surgery 2,077 cases Better 4.13 per 1,000 likely 0.85 per 1,000 – 7.4 per 1,000 9.42 per 1,000
Blood clots in the lungs or legs after surgery 5,246 cases No different 2.82 per 1,000 likely 1.5 per 1,000 – 4.14 per 1,000 3.52 per 1,000
Sepsis after surgery 2,251 cases Better 3.12 per 1,000 likely 1.01 per 1,000 – 5.23 per 1,000 5.27 per 1,000
Surgical wound splitting open 1,122 cases No different 1.47 per 1,000 likely 0.19 per 1,000 – 2.74 per 1,000 1.77 per 1,000
Accidental cut or tear during abdominal surgery 3,885 cases No different 0.6 per 1,000 likely 0 per 1,000 – 1.32 per 1,000 1.06 per 1,000

Infections caught in the hospital

Standardized infection ratio: 1.0 means as many infections as CMS predicted for a hospital like this one. Lower is better. Data from Oct 2024 – Sep 2025.

4 better than the nation 2 no different
Measure CMS comparison This hospital National
Bloodstream infections from central lines (CLABSI) Better 0.57 likely 0.41 – 0.79 1
Urinary tract infections from catheters (CAUTI) Better 0.37 likely 0.24 – 0.55 1
Surgical site infections after colon surgery No different 0.91 likely 0.55 – 1.42 1
Surgical site infections after abdominal hysterectomy No different 0.46 likely 0.08 – 1.5 1
MRSA bloodstream infections Better 0.58 likely 0.37 – 0.89 1
C. diff intestinal infections Better 0.37 likely 0.3 – 0.46 1

Readmissions and return visits

How often patients had to come back to a hospital after going home. Lower is better. Data from Jul 2023 – Jun 2025.

2 better than the nation 2 no different
Measure CMS comparison This hospital National
Readmitted after a heart attack 705 cases Too few cases 15.4% 14.4%
Readmitted after heart failure 2,419 cases Too few cases 21.6% 21.3%
Readmitted after pneumonia 2,832 cases Too few cases 19.1% 17.3%
Readmitted after COPD 665 cases Too few cases 22.3% 20%
Readmitted after heart bypass surgery 204 cases Too few cases 13.6% 11%
Readmitted after hip or knee replacement 260 cases Too few cases 6.2% 5.8%
Days back in hospital after a heart attack 463 cases Too few cases 18.4 days per 100 —
Days back in hospital after heart failure 1,281 cases Too few cases -1.6 days per 100 —
Days back in hospital after pneumonia 1,650 cases Too few cases 20.5 days per 100 —
Unplanned visits after an outpatient colonoscopy 1,259 cases No different 13.3 per 1,000 likely 10.3 per 1,000 – 17.2 per 1,000 13 per 1,000
Hospital admissions during outpatient chemotherapy 1,744 cases No different 11.2 per 100 likely 10 per 100 – 12.7 per 100 10.7 per 100
ER visits during outpatient chemotherapy 1,744 cases Better 3.7 per 100 likely 3.1 per 100 – 4.6 per 100 5.4 per 100
Unplanned visits after outpatient surgery 1,640 cases Better 0.8 likely 0.7 – 1 —

1 more measure had too few cases here to report.

Clinicians registered at this address

74 clinicians give this hospital's street address as their practice location in NPPES, the federal provider registry. The same address can take in offices and clinics in the building, and a listing does not prove admitting privileges or current employment.

Specialty Clinicians
Medical 18
Hospitalist 17
Clinical 8
Internal Medicine 4
Physician Assistant 4
Family 3
Anatomic Pathology 2
Emergency Medicine 2
Neonatal-Perinatal Medicine 2
Nurse Practitioner 2
Pediatrics 2
Surgical 2

First 12 alphabetically

Money from drug and device companies

Drug and device makers have to report what they pay teaching hospitals to CMS's Open Payments program. At many teaching hospitals most of it is research funding, or royalties for inventions the hospital licensed to a company. A payment on its own does not show a conflict of interest.

2025 total $3M general $269,573 · research $2.7M
All years, 2019–2025 $12.9M 1,411 reported payments
Studies funded, 2025 36 38 companies paid in total
  • 2019 $1.9M
  • 2020 $1.9M
  • 2021 $1.1M
  • 2022 $1.3M
  • 2023 $1.4M
  • 2024 $2.4M
  • 2025 $3M

General payments Research payments

What the 2025 general payments were for

Type of payment Amount Payments
Speaking, teaching and other services $127,381 23
Grants $49,879 9
Medical devices and supplies on long-term loan $37,242 4
Space rental and facility fees $28,553 13
Debt forgiveness $18,744 6
Education $5,125 2
Honoraria $2,424 1
Charitable contributions $225 3

Largest paying companies, 2025

Company Amount Payments
Abbvie INC. $746,059 4
Boston Scientific Corporation $410,000 2
Novartis Pharmaceuticals Corporation $375,570 9
E.R. Squibb & Sons, L.L.C. $270,550 6
Siemens Medical Solutions USA, Inc. $207,338 5
Karyopharm Therapeutics Inc. $165,442 84
Pfizer INC. $140,596 10
Merck Sharp & Dohme LLC $120,314 1

Largest research studies funded here, 2025

Study Amount
A phase II evaluation of the safety and efficacy of mirvetuximab soravtansine (IMGN853) in women with folate receptor positive persistent or recurren… ABBVIE INC. $610,412
Concomitant Atrial Fibrillation Ablation and Left Atrial Appendage Occlusion in Real-World Practice Boston Scientific Corporation $410,000
A Phase II Adjuvant Trial Evaluating the Impact of Omitting Chemotherapy Based on Patients Selection for Moderate to High/Anatomical Risk, Low/Genomi… Novartis Pharmaceuticals Corporation $247,595
Personalized task-based respiratory motion correction for low-dose PET-CT Siemens Medical Solutions USA, Inc. $189,280
A Phase 2 Study to Evaluate the Efficacy and Safety of Selinexor in Patients with High-Risk Myelofibrosis Karyopharm Therapeutics Inc. $165,442
A randomized phase II trial of Mirvetuximab soravtansine (IMGN853), in BRCA wild-type, folate receptor alpha (FR)-positive recurrent ovarian cancer e… ABBVIE INC. $135,647
STUDY NAME#A phase II study of NC318 alone or in combination with Pembrolizumab in patients with advanced non-small cell lung cancer Merck Sharp & Dohme LLC $120,314
A Phase 3 Randomized, Double-blind Study of Ianalumab (VAY736) Versus Placebo in Addition to Eltrombopag in Patients With Primary Immune Thrombocytop… Novartis Pharmaceuticals Corporation $100,444

Amounts are as the paying companies reported them to CMS; Open Payments data retrieved 13 Sep 2026. Full record on CMS Open Payments.

How to read this page

  • Everything here is published by CMS on Care Compare. We arrange it and explain it; the star ratings and the better / worse verdicts are CMS's, not ours.
  • “No different” is the most common result on most measures at most hospitals. CMS only calls a result better or worse when the difference from the national rate is statistically clear.
  • Death, complication and readmission rates are adjusted by CMS for how sick patients were, so hospitals that treat sicker patients can be compared fairly.
  • Infection results are ratios: 1.0 means as many infections as CMS predicted for a hospital like this one, below 1.0 is fewer.
  • These are hospital-wide results. They do not rate an individual doctor, nurse or department, and they are not medical advice.

CMS Care Compare data retrieved 4 Oct 2026, refreshed weekly. Where this data comes from and how we handle it · Report an error

Common questions about Yale-New Haven Hospital

Is Yale-New Haven Hospital a good hospital?

Yale-New Haven Hospital has a CMS overall rating of 5 out of 5 stars. Of the 27 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 11 and worse on 3. These are hospital-wide results published by CMS; they do not rate individual doctors or departments.

Would patients recommend Yale-New Haven Hospital?

69% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. The figure comes from 863 completed HCAHPS surveys.

How long is the wait in the Yale-New Haven Hospital emergency room?

Emergency patients spend a median of 3 h 18 min in its emergency department before leaving (US median 2 h 42 min). Among US emergency departments with very high patient volume, like this one, the median is 3 h 21 min. 2% of emergency patients left before being seen (US 2%). These are medians over a year of visits, not a live wait time.

Does Yale-New Haven Hospital receive money from drug and device companies?

Drug and device makers reported $3M in payments to Yale-New Haven Hospital for 2025, most of it research funding, under the federal Open Payments program. A payment on its own does not show a conflict of interest.